Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,400.96
(
-0.16%
)
US TECH 100
28,493.60
(
0.72%
)
Dow Jones
49,760.56
(
0.11%
)
Brent Oil
105.38
(
-0.36%
)
Bitcoin
81,233.33
(
0.92%
)
News Focus
News Focus

Replies to post #242373 on Biotech Values

Replies to #242373 on Biotech Values
icon url

DewDiligence

05/07/22 2:11 PM

#242377 RE: dewophile #242373

CLVS—OS HR>1.0 is generally a deal-killer even when PFS is the primary endpoint.
icon url

DewDiligence

09/11/22 5:13 PM

#243799 RE: dewophile #242373

CLVS continues to show strong PFS data in ovarian cancer first-line-maintenance, while waiting for the OS data to mature; these results were presented as ESMO this weekend:

https://www.businesswire.com/news/home/20220911005019/en